Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway.

Liu X, Liu J, Meng Q, Shao Y

Open source

DOI
10.32604/or.2026.082954
Published
2026
Container
Oncology research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.32604/or.2026.082954,
  title = {Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway.},
  author = {Liu X and Liu J and Meng Q and Shao Y},
  year = {2026},
  journal = {Oncology research},
  doi = {10.32604/or.2026.082954},
  url = {https://doi.org/10.32604/or.2026.082954}
}

RIS

TY  - JOUR
TI  - Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway.
AU  - Liu X
AU  - Liu J
AU  - Meng Q
AU  - Shao Y
PY  - 2026
JO  - Oncology research
DO  - 10.32604/or.2026.082954
UR  - https://doi.org/10.32604/or.2026.082954
ER  - 

APA

X, L., J, L., Q, M., & Y, S. (2026). Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway.. Oncology research. https://doi.org/10.32604/or.2026.082954

Source records